Skip to Main Content


This podcast is produced by pharmacy faculty to supplement study material and provide relevant drug and professional topics. We're hoping that our real-life clinical pearls and discussions will help you stay up-to-date and improve your pharmacy knowledge.

How Do I Listen?

HelixTalk is available via Apple Podcasts (or by searching for HelixTalk), by subscribing to our RSS feed, subscribing to our mailing list, or by listening to any episode in your browser (below).

Subscribe to Our Mailing List

HelixTalk Episodes

HelixTalk #149 - Replenishing the Missing Element: A Complete Review of Iron Deficiency Anemia

Date posted: June 14, 2022, 6:00 am

In this episode, we will cover a complete overview of definition, diagnosis, treatment and monitoring of iron deficiency anemia (IDA).

HelixTalk #148 - Grit, Determination, and Entrepreneurship: A Pharmacist’s Career Path to Starting an Independent Pharmacy

Date posted: May 24, 2022, 6:00 am

In this episode, we interview Hetal Patel, PharmD and RFUMS COP alumnus, regarding her career path that eventually led her to open Lebanon Family Pharmacy in TN in 2021. We discuss the challenges and opportunities of starting a new independent pharmacy and what the future of independent pharmacy looks like.

HelixTalk #147 - Key Recommendations from the 2022 AHA/ACC/HFSA Heart Failure Guidelines

Date posted: May 3, 2022, 6:00 am

In this episode, we review new updates and key concepts from the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. This guideline is newly published (April 2022) and is a full update of the 2013 guidelines and the 2017 focused update for heart failure.

HelixTalk #146 - New Drugs for Bad Bugs: Six Newer Antibiotics for Multidrug Resistant Pathogens

Date posted: April 12, 2022, 6:00 am

In this episode, we discuss six newer antibiotics that target multidrug resistant gram negative bacteria with Dr. Christie Bertram, PharmD, BCIDP. We review common resistance mechanisms, particularly to carbapenems, and highlight the current role in therapy for the following antibiotics: ceftolozane/tazobactam (Zerbaxa®), ceftazidime/avibactam (Avycaz®), meropenem/vaborbactam (Vabomere®), imipenem/cilastatin/relebactam (Recarbrio®), cefiderocol (Fetroja®), and eravacycline (Xerava®).